When Major Bleeding Extends Beyond Hospitalization – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Nicholas S. Roetker et al. published in RTPH:
“Major bleeding is not just more common in dialysis; it is more costly after it happens.
In a new Medicare-based study published in RPTH Journal, patients with dialysis-dependent ESKD had longer and more expensive hospitalizations for major bleeding than patients without ESKD.
One year later, the burden remained high: bleeding-related hospitalizations were more frequent, costs were substantially higher, and readmissions were a major driver.
A sharp reminder that bleeding prevention in dialysis is not only a clinical priority, it is also a major health-system priority.”
Title: Health care resource utilization and costs of major bleeding in patients with and without dialysis-dependent end-stage kidney disease: a retrospective study
Authors: Nicholas S. Roetker, Alejandro Victores, Chuanyu Kou, Lori D. Bash, Dena Rosen Ramey, Xuehua Ke, Marc P. Bonaca, James B. Wetmore
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 1, 2026, 14:04Sinju Thomas: Strengthening Apheresis Excellence Through Shared Learning
-
Jul 1, 2026, 14:02Nikola Pantic: Advances in Diagnosis and Treatment of Hematological Diseases
-
Jul 1, 2026, 13:55Omar Adwan: The Diagnostic Value of Schistocytes in Hemolytic Disorders
-
Jul 1, 2026, 13:47Mostafa Faisal: Advancing Care in β-Thalassemia With Luspatercept
-
Jul 1, 2026, 13:40Tran-Hai-Yen Nguyen: Connecting with the Global Blood Transfusion Community at ISBT 2026
-
Jul 1, 2026, 13:29Farjah Algahtani: Joining the Global Conversation at ISTH 2026
-
Jul 1, 2026, 12:14Ney Carter Borges: Simplifying Blood Pressure Control After Intracerebral Hemorrhage
-
Jul 1, 2026, 12:11Ifeanyichukwu Ifechidere: DOAC Monitoring – What To Order, When, And Why
-
Jul 1, 2026, 12:01Nathan Connell: Tranexamic Acid – Small Intervention, Big Impact